Vericel (VCEL) EBITDA Margin: 2010-2025
Historic EBITDA Margin for Vericel (VCEL) over the last 16 years, with Sep 2025 value amounting to 5.11%.
- Vericel's EBITDA Margin rose 937.00% to 5.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.75%, marking a year-over-year increase of 329.00%. This contributed to the annual value of 1.90% for FY2024, which is 518.00% up from last year.
- As of Q3 2025, Vericel's EBITDA Margin stood at 5.11%, which was up 259.30% from -3.21% recorded in Q2 2025.
- In the past 5 years, Vericel's EBITDA Margin registered a high of 24.52% during Q4 2024, and its lowest value of -24.52% during Q2 2022.
- Over the past 3 years, Vericel's median EBITDA Margin value was -10.66% (recorded in 2024), while the average stood at -4.43%.
- The largest annual percentage gain for Vericel's EBITDA Margin in the last 5 years was 3,232bps (2021), contrasted with its biggest fall of 2,528bps (2021).
- Vericel's EBITDA Margin (Quarterly) stood at 8.70% in 2021, then soared by 285bps to 11.55% in 2022, then skyrocketed by 804bps to 19.59% in 2023, then soared by 493bps to 24.52% in 2024, then surged by 937bps to 5.11% in 2025.
- Its EBITDA Margin was 5.11% in Q3 2025, compared to -3.21% in Q2 2025 and -24.32% in Q1 2025.